Research graph
References from A Post-Pandemic Surge in Pediatric Epstein–Barr Virus Infection: A Six-Year Single- Center Retrospective Study in China, 2019–2024. Local targets link to admitted publications; unresolved targets remain external evidence.
Surge: Sustained High Prevalence and Epidemiological Shift in Pediatric Epstein–Barr Virus Infection
10.3390/pathogens15040361 · 2026 · External reference
Progress and Problems in Understanding and Managing Primary Epstein-Barr Virus Infections
10.1128/cmr.00044-10 · 2011 · External reference
Age-Dependent Clinical Patterns of Primary Epstein-Barr Virus Infection in Children: Insights for Diagnostic Accuracy
10.3390/pathogens15050554 · 2026 · External reference
Epidemiology of Epstein-Barr virus infection and infectious mononucleosis in the United Kingdom
10.1186/s12889-020-09049-x · 2020 · External reference
Estimating the global burden of Epstein-Barr virus-related cancers
10.1007/s00432-021-03824-y · 2022 · External reference
Landscape of EBV-positive gastric cancer
10.1007/s10120-021-01215-3 · 2021 · External reference
EBV Infection and Its Regulated Metabolic Reprogramming in Nasopharyngeal Tumorigenesis
10.3389/fcimb.2022.935205 · 2022 · External reference
Epstein Barr Virus-Associated Hodgkin Lymphoma
10.3390/cancers10060163 · 2018 · External reference
Epstein-Barr Virus and Systemic Autoimmune Diseases
10.3389/fimmu.2020.587380 · 2021 · External reference
How EBV Infects: The Tropism and Underlying Molecular Mechanism for Viral Infection
10.3390/v14112372 · 2022 · External reference
The clinical significance of EBV DNA in the plasma and peripheral blood mononuclear cells of patients with or without EBV diseases
10.1182/blood-2015-09-672030 · 2016 · External reference
Molecular Basis of Epstein-Barr Virus Latency Establishment and Lytic Reactivation
10.3390/v13122344 · 2021 · External reference
Change of epidemiological characteristics of four respiratory viral infections in children before and during COVID-19 pandemic
10.1016/j.idnow.2024.104858 · 2024 · External reference
Changes of Mycoplasma pneumoniae prevalence in children before and after COVID-19 pandemic in Henan, China
10.1016/j.jinf.2022.12.030 · 2023 · External reference
Epidemiological changes of common respiratory viruses in children during the COVID-19 pandemic
10.1002/jmv.27570 · 2022 · External reference
Analyzing infections caused by 11 respiratory pathogens in children: Pre- and post-COVID-19 pandemic trends in China
10.1002/jmv.29929 · 2024 · External reference
Post-Pandemic Epidemiology of Respiratory Infections among Pediatric Inpatients in a Tertiary Hospital in Shanghai, China
10.3390/children11091127 · 2024 · External reference
Epidemiological characteristics and disease burden of infectious mononucleosis in hospitalized children in China: A nationwide retrospective study
10.1016/j.virs.2022.07.007 · 2022 · External reference
Changes in Epstein-Barr virus infections in the children before and after the COVID-19 pandemic in Zhengzhou, China
10.1002/jmv.28597 · 2023 · External reference
Six-year epidemiological dynamics of human respiratory syncytial virus infections in children in central China (2019–2024): pandemic suppression, 2023 resurgence, and immune debt effect
10.3389/fcimb.2025.1691957 · 2025 · External reference
Macrolide-resistant Mycoplasma pneumoniae resurgence in Chinese children in 2023: a longitudinal, cross-sectional, genomic epidemiology study
10.1016/j.lanmic.2025.101200 · 2025 · External reference
Verification of Immune Debts in Children Caused by the COVID-19 Pandemic from an Epidemiological and Clinical Perspective
10.3390/immuno5010005 · 2025 · External reference
Pandemic-Driven Shifts in Epstein-Barr Virus (EBV) Epidemiology: Single Center Study
10.3390/v17030375 · 2025 · External reference
Epstein-Barr virus: the mastermind of immune chaos
10.3389/fimmu.2024.1297994 · 2024 · External reference
Association and Interaction of Epstein-Barr Virus with SARS-CoV-2 Infection-A Review
10.3390/v17070903 · 2025 · External reference
What could cause the reactivation of Epstein-Barr virus in individuals with long COVID
10.1080/22221751.2025.2552712 · 2025 · External reference
The SARS-CoV-2 trigger highlights host interleukin 1 genetics in Epstein-Barr virus reactivation
10.1016/j.celrep.2025.115859 · 2025 · External reference
COVID-19 infection and vaccines: potential triggers of Herpesviridae reactivation
10.1016/j.abd.2022.09.004 · 2023 · External reference
High incidence of Epstein-Barr virus, cytomegalovirus, and human-herpes virus-6 reactivations in critically ill patients with COVID-19
10.1016/j.idnow.2021.01.005 · 2021 · External reference
Positive Epstein-Barr virus detection in coronavirus disease 2019 (COVID-19) patients
10.1038/s41598-021-90351-y · 2021 · External reference
EBV DNA increase in COVID-19 patients with impaired lymphocyte subpopulation count
10.1016/j.ijid.2020.12.051 · 2021 · External reference
Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection
10.1038/s41590-021-01113-x · 2022 · External reference
Epstein Barr Virus Reactivation during COVID-19 Hospitalization Significantly Increased Mortality/Death in SARS-CoV-2(+)/EBV(+) than SARS-CoV-2(+)/EBV(–) Patients: A Comparative Meta-Analysis
10.1155/2023/1068000 · 2023 · External reference
The interactions of SARS-CoV-2 with cocirculating pathogens: Epidemiological implications and current knowledge gaps
10.1371/journal.ppat.1011167 · 2023 · External reference
